Basic information
- CAS
931-49-7- Standard SMILES
C#CC1=CCCCC1- InChIKey
DKFHWNGVMWFBJE-UHFFFAOYSA-N- Molecular formula
- C8H10
- Average molar mass
- 106.16 g/mol
- Monoisotopic mass
- 106.07825032
Overview
structure in first source
Names & identifiers
- Preferred name
- 1-Ethynylcyclohexene
- IUPAC
- 1-ethynylcyclohexene
- English name
- 1-Ethynylcyclohexene
- Molecular formula
- C8H10
- Molecular weight
- 106.17
Names & synonyms
Show more names
Database identifiers
- CAS
931-49-7- PubChem CID
- 79128
- DTXSID
DTXSID5073244- ChEMBL
CHEMBL232741- UNII
- 7TJ42SRP2Z
- EC Number
- 618-915-4
- Nikkaji
- J329.372F
Properties
Computed structural properties
- XLogP
- 2.3
- Topological polar surface area
- 0 Ų
- Hydrogen bond donors
- 0
- Hydrogen bond acceptors
- 0
- Rotatable bonds
- 1
- Heavy atoms
- 8
- Formal charge
- 0
- Complexity
- 143
Experimental & physicochemical properties
Physicochemical properties
- Boiling point
- 148 · 148-151 °C(lit.)
- Density
- 0.903 g/mL · 0.903 g/mL at 25 °C(lit.)
- refractive index
- 20 · n20/D 1.496(lit.)
- Flash point
- 85 °F · 85 °F
- storage temp.
- 2 · 2-8°C
- form
- clear liquid
- color
- Colorless to Light orange to Yellow
- λmax
- 224 nm · 224nm(EtOH)(lit.)
- InChI
- 1S/C8H10/c1-2-8-6-4-3-5-7-8/h1,6H,3-5,7H2
- InChIKey
- DKFHWNGVMWFBJE-UHFFFAOYSA-N
- SMILES
- C#CC1=CCCCC1
- FDA 21 CFR
- 175.32 · 175.320
- Indirect Additives used in Food Contact Substances
- 1 · 1-ETHYNYLCYCLOHEXENE
- FDA UNII
- 7 TJ42SRP2Z · 7TJ42SRP2Z
- EPA Substance Registry System
- 1 · Cyclohexene, 1-ethynyl- (931-49-7)
- UNSPSC Code
- 12352100 · 12352100
- NACRES
- 22 · NA.22
- Symbol(GHS)
- 2 · GHS02,GHS07
- Signal word
- Warning
- Hazard statements
- 226 · H226-H315-H319-H335
- Precautionary statements
- 210 · P210-P302+P352-P305+P351+P338
- target organs
- Respiratory system
- PPE
- Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
- Hazard Codes
- Xi
- Risk Statements
- 10 · 10-36/37/38
- Safety Statements
- 16 · 16-26-36/37/39
- RIDADR
- 3295 · UN 3295 3/PG 3
- WGK Germany
- 3 · 3
- HazardClass
- 3.2 · 3.2
- PackingGroup
- III
- HS Code
- 2902110000 · 2902110000
- Storage Class
- 3 · 3 - Flammable liquids
- Hazard Classifications
- 2 Flam · Eye Irrit. 2Flam. Liq. 3Skin Irrit. 2STOT SE 3
- Limited Quantities
- 5 L · 5.0 L (1.3 gallons) (liquid)
- Excepted Quantities
- Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L)
Safety & regulation
GHS classification
GHS Classification
Warning
H226 (100%): Flammable liquid and vapor [Warning Flammable liquids]
P210, P233, P240, P241, P242, P243, P261, P264, P264+P265, P271, P280, P302+P352, P303+P361+P353, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P370+P378, P403+P233, P403+P235, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard information
Regulatory Information
Chemical: Cyclohexene, 1-ethynyl-
Cyclohexene, 1-ethynyl-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Safety data
- PPE
- Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
- wgk
- 3
- ridadr
- UN 3295 3/PG 3
- hs_code
- 2902110000
- risk_code
- 10-36/37/38
- Signal word
- Warning
- Symbol(GHS)
- GHS02,GHS07
- hazard_code
- Xi
- safety_code
- 16-26-36/37/39
- hazard_class
- 3.2
- Storage Class
- 3 - Flammable liquids
- packing_group
- III
- target organs
- Respiratory system
- Hazard statements
- H226-H315-H319-H335
- Limited Quantities
- 5.0 L (1.3 gallons) (liquid)
- Excepted Quantities
- Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L)
- Hazard Classifications
- Eye Irrit. 2Flam. Liq. 3Skin Irrit. 2STOT SE 3
- Precautionary statements
- P210-P302+P352-P305+P351+P338
Chemistry & industry
Applications
Uses1-ETHYNYLCYCLOHEXENE can be used to prepare 4-phenoxyquinoline-N-sulfonylamidine compounds with the following structure. These compounds can act as tyrosine kinase inhibitors, especially c-Met inhibitors. c-Met is highly expressed in most solid tumors and some sarcomas and is closely associated with poor prognosis, such as lung cancer, breast cancer, colon cancer, prostate cancer, liver cancer, gastric cancer, and glioma. Furthermore, patients with high HGF/c-Met expression levels have stronger resistance to chemotherapy and radiotherapy. Besides abnormal HGF/c-Met expression, c-Met can also be activated in cancer patients through gene mutation and gene amplification.
Upstream & downstream products
Downstream products
Suppliers46 total
Related reactions
Compound notes
Loading…